Therapeutic reference ranges for psychotropic drugs: a protocol for systematic reviews

Background: For many psychotropic drugs, monitoring of drug concentrations in the blood (Therapeutic Drug Monitoring; TDM) has been proven useful to individualize treatments and optimize drug effects. Clinicians hereby compare individual drug concentrations to population-based reference ranges for a...

Full description

Saved in:
Bibliographic Details
Main Authors: Hart, Xenia Marlene (Author) , Eichentopf, Luzie (Author) , Lense, Xenija M. (Author) , Riemer, Thomas Günther (Author) , Wesner, Katja (Author) , Hiemke, Christoph (Author) , Gründer, Gerhard (Author)
Format: Article (Journal)
Language:English
Published: 24 November 2021
In: Frontiers in psychiatry
Year: 2021, Volume: 12, Pages: 1-6
ISSN:1664-0640
DOI:10.3389/fpsyt.2021.787043
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fpsyt.2021.787043
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/article/10.3389/fpsyt.2021.787043
Get full text
Author Notes:Xenia M. Hart, Luzie Eichentopf, Xenija Lense, Thomas Riemer, Katja Wesner, Christoph Hiemke and Gerhard Gründer

MARC

LEADER 00000caa a2200000 c 4500
001 1783559403
003 DE-627
005 20240415120635.0
007 cr uuu---uuuuu
008 211223s2021 xx |||||o 00| ||eng c
024 7 |a 10.3389/fpsyt.2021.787043  |2 doi 
035 |a (DE-627)1783559403 
035 |a (DE-599)KXP1783559403 
035 |a (OCoLC)1295644161 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hart, Xenia Marlene  |d 1994-  |e VerfasserIn  |0 (DE-588)1248335058  |0 (DE-627)1783559357  |4 aut 
245 1 0 |a Therapeutic reference ranges for psychotropic drugs  |b a protocol for systematic reviews  |c Xenia M. Hart, Luzie Eichentopf, Xenija Lense, Thomas Riemer, Katja Wesner, Christoph Hiemke and Gerhard Gründer 
264 1 |c 24 November 2021 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.12.2021 
520 |a Background: For many psychotropic drugs, monitoring of drug concentrations in the blood (Therapeutic Drug Monitoring; TDM) has been proven useful to individualize treatments and optimize drug effects. Clinicians hereby compare individual drug concentrations to population-based reference ranges for a titration of prescribed doses. Thus, established reference ranges are pre-requisite for TDM. For psychotropic drugs, guideline-based ranges are mostly expert recommendations derived from a conglomerate of cohort and cross-sectional studies. A systematic approach for identifying therapeutic reference ranges has not been published yet. This paper describes how to search, evaluate and grade the available literature and validate published therapeutic reference ranges for psychotropic drugs.Methods/Results: Following PRISMA guidelines, relevant databases have to be systematically searched using search terms for the specific psychotropic drug, blood concentrations, drug monitoring, positron emission tomography (PET) and single photon emission computed tomography (SPECT). The search should be restricted to humans, and diagnoses should be pre-specified. Therapeutic references ranges will not only base upon studies that report blood concentrations in relation to clinical effects, but will also include implications from neuroimaging studies on target engagement. Furthermore, studies reporting concentrations in representative patient populations are used to support identified ranges. Each range will be assigned a level of underlying evidence according to a systematic grading system.Discussion: Following this protocol allows a comprehensive overview of TDM literature that supports a certain reference range for a psychotropic drug. The assigned level of evidence reflects the validity of a reported range rather than experts' opinions. 
700 1 |a Eichentopf, Luzie  |d 1990-  |e VerfasserIn  |0 (DE-588)1276287623  |0 (DE-627)1828242055  |4 aut 
700 1 |a Lense, Xenija M.  |d 1997-  |e VerfasserIn  |0 (DE-588)1278513981  |0 (DE-627)1831439077  |4 aut 
700 1 |a Riemer, Thomas Günther  |d 1979-  |e VerfasserIn  |0 (DE-588)1076418368  |0 (DE-627)834852594  |0 (DE-576)445329939  |4 aut 
700 1 |a Wesner, Katja  |d 1984-  |e VerfasserIn  |0 (DE-588)1325960853  |0 (DE-627)1885694520  |4 aut 
700 1 |a Hiemke, Christoph  |d 1948-  |e VerfasserIn  |0 (DE-588)1145417272  |0 (DE-627)1006549528  |0 (DE-576)161418430  |4 aut 
700 1 |a Gründer, Gerhard  |e VerfasserIn  |0 (DE-588)1078251037  |0 (DE-627)838195350  |0 (DE-576)449927644  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in psychiatry  |d Lausanne : Frontiers Research Foundation, 2007  |g 12(2021) vom: 24. Nov., Artikel-ID 787043, Seite 1-6  |h Online-Ressource  |w (DE-627)631498796  |w (DE-600)2564218-2  |w (DE-576)326550968  |x 1664-0640  |7 nnas  |a Therapeutic reference ranges for psychotropic drugs a protocol for systematic reviews 
773 1 8 |g volume:12  |g year:2021  |g day:24  |g month:11  |g elocationid:787043  |g pages:1-6  |g extent:6  |a Therapeutic reference ranges for psychotropic drugs a protocol for systematic reviews 
856 4 0 |u https://doi.org/10.3389/fpsyt.2021.787043  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/article/10.3389/fpsyt.2021.787043  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230724 
993 |a Article 
994 |a 2021 
998 |g 1078251037  |a Gründer, Gerhard  |m 1078251037:Gründer, Gerhard  |d 60000  |e 60000PG1078251037  |k 0/60000/  |p 7  |y j 
998 |g 1325960853  |a Wesner, Katja  |m 1325960853:Wesner, Katja  |d 60000  |e 60000PW1325960853  |k 0/60000/  |p 5 
998 |g 1278513981  |a Lense, Xenija M.  |m 1278513981:Lense, Xenija M.  |d 60000  |e 60000PL1278513981  |k 0/60000/  |p 3 
998 |g 1276287623  |a Eichentopf, Luzie  |m 1276287623:Eichentopf, Luzie  |d 60000  |e 60000PE1276287623  |k 0/60000/  |p 2 
998 |g 1248335058  |a Hart, Xenia Marlene  |m 1248335058:Hart, Xenia Marlene  |d 60000  |e 60000PH1248335058  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1783559403  |e 435714129X 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.3389/fpsyt.2021.787043"],"eki":["1783559403"]},"physDesc":[{"extent":"6 S."}],"relHost":[{"name":{"displayForm":["Frontiers Research Foundation"]},"note":["Gesehen am 18.11.2020"],"disp":"Therapeutic reference ranges for psychotropic drugs a protocol for systematic reviewsFrontiers in psychiatry","id":{"eki":["631498796"],"zdb":["2564218-2"],"issn":["1664-0640"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Lausanne","dateIssuedKey":"2007","publisher":"Frontiers Research Foundation","dateIssuedDisp":"2007-"}],"recId":"631498796","type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"1-6","extent":"6","volume":"12","year":"2021","text":"12(2021) vom: 24. Nov., Artikel-ID 787043, Seite 1-6"},"language":["eng"],"title":[{"title":"Frontiers in psychiatry","title_sort":"Frontiers in psychiatry"}],"pubHistory":["2007 -"]}],"note":["Gesehen am 23.12.2021"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"24 November 2021"}],"recId":"1783559403","type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Hart, Xenia Marlene","role":"aut","given":"Xenia Marlene","family":"Hart"},{"family":"Eichentopf","role":"aut","given":"Luzie","display":"Eichentopf, Luzie"},{"display":"Lense, Xenija M.","role":"aut","given":"Xenija M.","family":"Lense"},{"family":"Riemer","given":"Thomas Günther","role":"aut","display":"Riemer, Thomas Günther"},{"display":"Wesner, Katja","given":"Katja","role":"aut","family":"Wesner"},{"family":"Hiemke","display":"Hiemke, Christoph","given":"Christoph","role":"aut"},{"family":"Gründer","given":"Gerhard","role":"aut","display":"Gründer, Gerhard"}],"name":{"displayForm":["Xenia M. Hart, Luzie Eichentopf, Xenija Lense, Thomas Riemer, Katja Wesner, Christoph Hiemke and Gerhard Gründer"]},"title":[{"subtitle":"a protocol for systematic reviews","title":"Therapeutic reference ranges for psychotropic drugs","title_sort":"Therapeutic reference ranges for psychotropic drugs"}],"language":["eng"]} 
SRT |a HARTXENIAMTHERAPEUTI2420